Business & Finance
Pulmatrix reports first fiscal quarter financial results
14 May 2018 -

Pulmatrix Inc (NASDAQ: PULM), a US-based clinical stage biopharmaceutical company, reported its financial results for the first quarter of 2018 on Friday.

The company reported cash and cash equivalent of USD1.55m in the first quarter of 2018 compared to USD3.6m in the same period in 2017.

The firm generated USD0.2m of revenues in the first quarter of 2018 against no revenue in the first quarter of 2017. Net loss for the first quarter of 2018 was USD5.2m compared to a net loss of USD3.5m in the same period last year. The increase in net loss was attributable to certain increases in operating expense.

Login
Username:

Password: